TMCnet News
Fulcrum Therapeutics to Present at the 31st Annual Piper Jaffray Healthcare ConferenceCAMBRIDGE, Mass., Dec. 02, 2019 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that members of the management team will provide a business overview and update at the 31st Annual Piper Jaffray Healthcare Conference at 10:50 a.m. ET on Tuesday, December 3, 2019 in New York, NY. A live webcast of the presentation will be available through the investor relations section of the Company's website at About Fulcrum Therapeutics Investor Contact: Media Contact: |